You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

cell survival

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cartilage Degeneration, Rotator Cuff Tear, Osteoarthritis, Knee Trial (arthroscopy of the affected knee/ Bone Marrow Concentrate

Withdrawn
  • Cartilage Degeneration
  • +2 more
  • arthroscopy of the affected knee/ Bone Marrow Concentrate Injection
  • (no location specified)
Aug 24, 2022

Malignant Ovarian Germ Cell Tumors

Recruiting
  • Fertility Issues
  • observational study
  • Cairo, Egypt
    Department of Obstetrics & Gynecology
Jun 7, 2023

Sickle Cell Disease Without Crisis Trial in Chapel Hill (G6PD Deficient Red Blood Cell Transfusion, Non-G6PD deficient Red Blood

Recruiting
  • Sickle Cell Disease Without Crisis
  • G6PD Deficient Red Blood Cell Transfusion
  • Non-G6PD deficient Red Blood Cell Transfusion
  • Chapel Hill, North Carolina
    University of North Carolina at Chapel Hill
Aug 15, 2022

Sickle Cell Disease Trial in Atlanta (Biotin Labeled Red Blood Cells)

Recruiting
  • Sickle Cell Disease
  • Biotin Labeled Red Blood Cells
  • Atlanta, Georgia
  • +2 more
Nov 1, 2021

Following Salvage Surgery for RESidual or reCurrent sqUamous

Not yet recruiting
  • Head and Neck Cancer
  • Molecular Analyses
  • (no location specified)
Mar 28, 2023

Disease-free Survival of High-risk Head-neck Cutaneous Squamous

Active, not recruiting
  • Carcinoma, Squamous Cell
  • +5 more
  • Treatment
  • Maastricht, Netherlands
  • +1 more
Apr 26, 2023

Renal Cell Carcinoma, Neoadjuvant Trial (Axitinib plus Toripalimab, radical nephrectomy)

Not yet recruiting
  • Renal Cell Carcinoma
  • Neoadjuvant
  • Axitinib plus Toripalimab
  • radical nephrectomy
  • (no location specified)
Feb 12, 2023

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Aplastic Anemia Trial in Columbus (Health Promotion and Education, Medical

Active, not recruiting
  • Acute Lymphoblastic Leukemia
  • +11 more
  • Health Promotion and Education
  • +3 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Jul 24, 2023

Tumor Cell Survival Following EGFR, ALK, ROS1 or BRAF TKI

Recruiting
  • Non-Small Cell Carcinoma of Lung, TNM Stage 4
  • +5 more
    • Aurora, Colorado
      University of Colorado, Cancer Center
    Nov 3, 2021

    NSCLC Trial in Changsha (Time of immunotherapy infusion)

    Recruiting
    • Non-small Cell Lung Cancer
    • Time of immunotherapy infusion
    • Changsha, Hunan, China
      Hunan Cancer Hospital
    Dec 7, 2022

    Nomogram Predicting Survival in Chinese SCLC Patients

    Completed
    • Small Cell Lung Cancer
    • initial chemotherapy response
    • (no location specified)
    Jan 8, 2023

    Diabetes, Red Blood Cell Survival Trial in Iowa City (biotin labeled RBCs)

    Completed
    • Diabetes
    • Red Blood Cell Survival
    • biotin labeled RBCs
    • Iowa City, Iowa
      University of Iowa
    Feb 4, 2022

    Two-field or Three-field Lymphadenectomy on Overall Survival in

    Completed
    • Esophageal Cancer
    • Since the data were collected retrospectively, there were no interventions
    • Chendu, Sichuan, China
      Sichuan Cancer Hospital
    Nov 18, 2022

    Nasal Vestibule Carcinoma, Rhinectomy, Nasal Vestibule Trial in France, Italy, United Kingdom (Rhinectomy)

    Recruiting
    • Nasal Vestibule Carcinoma
    • +3 more
    • Rhinectomy
    • Toulouse, Touluse, France
    • +5 more
    Jan 11, 2023

    RESECTED LYMPH NODES AND SURVIVAL OF PATIENTS WITH ESOPHAGEAL

    Recruiting
    • the Records of Esophageal Cancer
    • Since the data were collected retrospectively, there were no interventions
    • Chendu, Sichuan, China
      Sichuan Cancer Hospital
    Oct 24, 2022

    EGFR-TKI in Uncommon EGFR Mutant Advanced NSCLC

    Recruiting
    • Non-small Cell Lung Cancer
      • Changsha, Hunan, China
        Yongchang Zhang
      Feb 28, 2022

      Contrast-enhanced CT-based Deep Learning Model for Preoperative

      Recruiting
      • Predictive Ability of Contrast-enhanced CT-based Deep Learning Model in Patients With Localised ccRCC
      • +2 more
        • Chongqing, Chongqing, China
          Yingjie Xv
        Oct 12, 2023

        Survival Status of KRAS Mutation Advanced Non-small Cell Lung

        Enrolling by invitation
        • KRAS Gene Mutation Advanced Non-small Cell Lung Cancer
        • kras
        • Changsha, Hunan, China
          Hunan Cancer Hospital
        Mar 1, 2022

        Severe Toxicity Free Survival Following Childhood Acute

        Recruiting
        • Acute Lymphoblastic Leukemia
          • Copenhagen, Denmark
            Kjeld Schmiegelow
          Dec 9, 2022

          Aggressive Non-Hodgkin Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-Cell Lymphoma Trial in United States

          Active, not recruiting
          • Aggressive Non-Hodgkin Lymphoma
          • +14 more
          • Cholecalciferol
          • Laboratory Biomarker Analysis
          • Scottsdale, Arizona
          • +4 more
          Jan 16, 2023

          Geriatric Assessments in Elderly Diffuse Large B-cell Lymphoma

          Completed
          • Lymphoma, Large B-cell, Diffuse
            • Jeonju, Korea, Republic of
              Chonbuk National University Hospital
            Feb 2, 2023

            NSCLC, Stereotactic Body Radiotherapy, Comprehensive Geriatric Assessment Trial in Denmark (Comprehensive Geriatric Assessment)

            Recruiting
            • Non-small Cell Lung Cancer
            • +2 more
            • Comprehensive Geriatric Assessment
            • Aarhus, Aarhus N, Denmark
            • +3 more
            Jun 22, 2023

            Study of Factors Regulating Mast Cell Proliferation

            Recruiting
            • Mastocytosis
            • +3 more
              • Bethesda, Maryland
                National Institutes of Health Clinical Center
              Feb 2, 2023

              T1 Squamous Cell Carcinomas of the Lip

              Active, not recruiting
              • Lip
              • +9 more
                • Nijmegen, Gelderland, Netherlands
                • +2 more
                Nov 2, 2022

                Chronic Lymphocytic Leukemia (CLL) Trial

                Completed
                • Chronic Lymphocytic Leukemia (CLL)
                  • (no location specified)
                  Apr 5, 2022